EAPH (Easton Pharmaceuticals) YoY EBITDA Growth : 0.00% (As of Sep. 2021)

View and export this data going back to . Start your Free Trial

What is Easton Pharmaceuticals YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Easton Pharmaceuticals's YoY EBITDA Growth for the quarter that ended in Sep. 2021 was 0.00%.

Easton Pharmaceuticals's EBITDA per Share for the three months ended in Sep. 2021 was $0.00.

Easton Pharmaceuticals YoY EBITDA Growth Historical Data

The historical data trend for Easton Pharmaceuticals's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Easton Pharmaceuticals YoY EBITDA Growth Chart

Easton Pharmaceuticals Annual Data

Trend

Dec01

Dec02

Dec03

Dec04

Dec18

Dec19

Dec20

YoY EBITDA Growth

Get a 7-Day Free Trial

78.32

-21.72

100.00

Easton Pharmaceuticals Quarterly Data
	Jun02	Sep02	Dec02	Mar03	Jun03	Sep03	Dec03	Mar04	Jun04	Sep04	Dec04	Mar05	Jun05	Sep05	Dec18	Dec19	Dec20	Mar21	Jun21	Sep21
YoY EBITDA Growth	Get a 7-Day Free Trial															100.00	100.00	100.00	-	-

Easton Pharmaceuticals YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Easton Pharmaceuticals's YoY EBITDA Growth for the fiscal year that ended in Dec. 2020 is calculated as:

	YoY EBITDA Growth (A: Dec. 2020 )
=	(EBITDA per Share (A: Dec. 2020 )	-	EBITDA per Share (A: Dec. 2019 ))	/	\| EBITDA per Share (A: Dec. 2019 ) \|
=	(-0	-	-0)	/	\| -0 \|
=	N/A %

Easton Pharmaceuticals's YoY EBITDA Growth for the quarter that ended in Sep. 2021 is calculated as:

	YoY EBITDA Growth (Q: Sep. 2021 )
=	(EBITDA per Share (Q: Sep. 2021 )	-	EBITDA per Share (Q: Dec. 2019 ))	/	\| EBITDA per Share (Q: Dec. 2019 )) \|
=	(-0	-	0)	/	\| 0 \|
=	N/A %

Easton Pharmaceuticals YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Easton Pharmaceuticals's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Easton Pharmaceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Easton Pharmaceuticals Inc (OTCPK:EAPH) » Definitions » YoY EBITDA Growth

Comparable Companies

Traded in Other Exchanges

N/A

Address

2 Bloor Street East, Suite 3500, Toronto, ON, CAN, M4W 1A8

Website

http://www.eastonpharmaceuticalsinc.com

Easton Pharmaceuticals Inc is a diversified specialty pharmaceutical company. It owns and develops proprietary transdermal delivery technology and therapeutic over the counter products and drugs to treat cancer and other diseases. The company also owns exclusive distribution rights in Mexico and Latin America for patented women's diagnostic and preventative care products. It is focused on the development of product Viorra. The firm's products include Nauseasol, Skin Renou HA, Kenestrin gel, and XILIVE, among others.